No bird soars in a calm: therapeutic germline gene editing

Global healthcare systems spend trillions of dollars treating inherited diseases. Therapeutic germline gene editing has the potential to fundamentally shift medicine from treatment to prevention by genetically correcting the disease mutation at the embryo stage. Advances in precision genome editing and increased public support suggest that the field is ready for new clinical and regulatory pathways.